Breakthrough in Combat Against Sudan Ebolavirus: FDA Grants Orphan Drug Designation to Soligenix's SuVax™.
Late-stage Biopharmaceutical Company Granted FDA Approval For Orphan Drug Designation
Late-stage Biopharmaceutical Company Granted…
Late-stage Biopharmaceutical Company Granted FDA Approval For Orphan Drug Designation
Breakthrough in Combat Against Sudan Ebolavirus: FDA Grants Orphan Drug Designation to Soligenix's SuVax™.